Franklin Resources
ONCY

Franklin Resources’s Oncolytics Biotech ONCY Stock Holding History

Franklin Resources’s Portfolio ONCY Stock Details ONCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$75.8K Buy
79,842
+10,000
+14% +$9.27K ﹤0.01% 3016
2026
Q1 		$71.3K Hold
69,842
– – ﹤0.01% 2973
2025
Q4 		$72.3K Hold
69,842
– – ﹤0.01% 2953
2025
Q3 		$71.2K Buy
69,842
+6,567
+10% +$7.36K ﹤0.01% 2972
2025
Q2 		$48.4K Hold
63,275
– – ﹤0.01% 2911
2025
Q1 		$34.7K Buy
63,275
+50,609
+400% +$37K ﹤0.01% 2879
2024
Q4 		$11.7K Buy
+12,666
New +$13.2K ﹤0.01% 2878

Other funds holding ONCY

Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
SI
Seeds Investor New York $973M AUM 33.7% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $142M AUM 51.29% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $7.56B AUM 44.87% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
PI
PFG Investments Woodbury, New York $2.58B AUM 36.93% 1-Year Est. Return

Franklin Resources's ONCY Position: Q2 2026 in Review

Franklin Resources increased its Oncolytics Biotech (ONCY) stake by 14% in Q2 2026, buying an estimated $9.27K and bringing the position to 79,842 shares worth $75.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3016.

Franklin Resources first reported a position in ONCY in Q4 2024 and has held it in 7 quarters since. 75 funds tracked by Wall St. Rank hold ONCY as of Q2 2026.

  • Franklin Resources held 79,842 shares of Oncolytics Biotech worth $75.8K as of Q2 2026.
  • Franklin Resources bought 10,000 Oncolytics Biotech shares in Q2 2026, an estimated $9.27K.
  • Oncolytics Biotech made up ﹤0.01% of Franklin Resources's portfolio in Q2 2026, its #3016 holding.
  • Franklin Resources first reported a position in Oncolytics Biotech in Q4 2024 and has held it in 7 quarters since.
  • 75 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.